Jupiter Neurosciences, Inc. (JUNS)
NASDAQ: JUNS · Real-Time Price · USD
1.270
+0.020 (1.60%)
Sep 5, 2025, 12:36 PM - Market open

Jupiter Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
---0.230.641.13
Upgrade
Revenue Growth (YoY)
----63.44%-43.35%-
Upgrade
Cost of Revenue
1.520.490.950.941.451.64
Upgrade
Gross Profit
-1.52-0.49-0.95-0.71-0.81-0.52
Upgrade
Selling, General & Admin
4.252.62.922.723.11.34
Upgrade
Operating Expenses
4.252.62.922.723.11.34
Upgrade
Operating Income
-5.77-3.09-3.87-3.43-3.91-1.85
Upgrade
Interest Expense
-0.13-0.25-0.22-0.74-0.11-0.01
Upgrade
Interest & Investment Income
0.030.010000
Upgrade
Other Non Operating Income (Expenses)
0.060.040.190.26-0.090.28
Upgrade
EBT Excluding Unusual Items
-5.81-3.3-3.9-3.91-4.11-1.58
Upgrade
Other Unusual Items
-0.090.86-0.89-1.05-0.09-0.07
Upgrade
Pretax Income
-5.9-2.44-4.78-4.96-4.2-1.65
Upgrade
Net Income
-5.9-2.44-4.78-4.96-4.2-1.65
Upgrade
Net Income to Common
-5.9-2.44-4.78-4.96-4.2-1.65
Upgrade
Shares Outstanding (Basic)
322926252422
Upgrade
Shares Outstanding (Diluted)
322926252422
Upgrade
Shares Change (YoY)
18.72%9.01%3.75%6.69%9.51%5.01%
Upgrade
EPS (Basic)
-0.19-0.08-0.18-0.19-0.18-0.08
Upgrade
EPS (Diluted)
-0.19-0.08-0.18-0.19-0.18-0.08
Upgrade
Gross Margin
-----126.90%-45.74%
Upgrade
Operating Margin
----1471.38%-612.36%-164.41%
Upgrade
Profit Margin
----2125.15%-658.31%-146.92%
Upgrade
EBIT
-5.77-3.09-3.87-3.43-3.91-1.85
Upgrade
EBIT Margin
------164.41%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q